17^th Global Diabetes Conference & Nursing Care March 8-9, 2018 | Paris, France

Conference Series Ltd takes immense pleasure to extend our warm welcome to you all to 27^th European Diabetes Congress which will be happening in Rome, Italy from June 11-12, 2018 with the theme " New technologies and practical approaches in the field of diabetes and endocrine disorders".

Sessions/Tracks

Track 1: Physiology of diabetes

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 2: Diagnosis of Diabetes

Diabetes may be analysed based on plasma and glucose criteria or A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highly discussed in  ADA annual meeting.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 3: Diabetic Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods. The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e. the idiographic approach. Case studies permit an investigator to investigate a topic in far more detailed and minute way. The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 4: Symptoms and Treatment of Diabetes

Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations. The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes and direct our choices in choosing optimal therapies for type 1 and type 2 Diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 5: Diabetes in Market

Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 6: Complementary and Alternative Medicine

Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 7: Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play a vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 8: Endocrinology

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitor many important function of our body. When the hormone exits the gland they reach the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulate the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.  

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 9: Diabetes and its Complications

Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications.  Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 10: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually diabetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 11: Genetics and Diabetes

Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 12: Cell Therapy for Diabetes

Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells. The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 13: Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronic and etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries. 

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 14: Emerging Focus on Diabetes Research

Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology has observed the expansion of newer generation of Nano medicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rdMetabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany; 3^rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Diabetes Conferences | Endocrinology Conferences | France Meetings | Paris Meetings | Europe Conferences | Diabetes Expo | Conference Series

About the Conference:

With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 17^th Global Diabetes Conference & Nursing Care (Diabetes Global 2018) as a continuum of our previous successful conference. Diabetes Global 2018 will be held in Paris, France during March 08-09, 2018. The conference will focus on Applying Science and Technology to Fight Diabetes.

This conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring radical new approaches. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc.

For more details, please visit: http://globaldiabetes.conferenceseries.com/

Importance & Scope:

The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years1. WHO projects that diabetes will be the 7th leading cause of death in 2030.

Diabetes Global 2018 will feature the latest developments in research, diagonosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Societies Associated with Diabetes Research

International Diabetes Federation- Italy

Primary Care Diabetes Society

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedical Diabetes Research

Immunology of Diabetes Society

American Association of Diabetes Educators

American Diabetes Association

The Asian Association for the Study of Diabetes

International Association of the Diabetes and Pregnancy Study Groups

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Canadian Diabetes Association

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Association National Italian Diabetic Athletes

Italian Society of Diabetology

Market Value on Diabetic Research:

The impact of diabetes on the individual quality of life and general economy in Italy is substantial. Healthcare costs for patients with diabetes in Italy are estimated at approximately €5.5 billion annually, representing more than 6% of total national healthcare spending. The Cost of Diabetes in Europe—Type 2 Study(CODE-2), which measured the total healthcare costs for patients with type 2 diabetes in 8 European countries (Italy, Belgium, France, Germany, Netherlands, Spain, Sweden, and UK), found the total yearly (1998) costs for people with type 2 diabetes in Italy alone to be almost €5.2 billion, a per-patient expenditure of at least €2900. Among patients with type 2 diabetes in Italy examined by the CODE-2 study, 17.8% were hospitalized during the 6 month study, with an average hospital stay of 13 days. The cost of hospitalizations accounted for the greatest portion of total costs for all countries in the study, at 55%, leading non-antidiabetic drugs (21%), outpatient care (18%) and antidiabetic drugs (7%).[3] Among non-antidiabetic drugs, the majority were cardiovascular and lipid-lowering (42%).[3] Annual per-patient costs vary widely with primary treatment type, with the highest per-patient costs accrued by those treated with diet and exercise alone.

Diabetes Conferences | Endocrinology Conferences | France Meetings | Paris Meetings | Europe Conferences | Diabetes Expo | Conference Series